Cencora (COR) stock

Medicines wholesaler , market cap $63B

Medicines wholesaler

Market cap $63B

$337.84

+2.12%

After-hours $337.84 0.00%

As of 6:23 PM ET after-hours, delayed 15+ min · Live for Pro members

Quality Score

Average

In its industry

#3of 5

Drug Wholesale

Checks firing

5of 14

Trending up

From 52-week high

-10.5%

Above the 200-day

COR's Quality Score fell 2 points on Fri, Oct 30, to 10. Closed away from the day's high (2 chart checks stopped).

See COR's 14 chart checksSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on COR

Key facts on COR
The company	Profit up 38% to $2.6B
Latest filing	8-K, Oct 21 Reported its quarterly results

1 more reason behind COR's 10, free with an account →2 more reasons behind COR's 10, for Pro members.

COR in the news

ReportReports Wednesday, before the open. Every 3 months, a company tells everyone how much it sold and earned. It fell after 3 of its last 4 reports, -5.9% on average. Past reports ›

COR catalysts

Coming up

After its last 4 reports it closed -5.9% on average, higher 1 of 4 times.

36 past catalysts since 2018, with sizes and sources, for Pro members.Get in free →

Why COR scores 10

Averagefor quality, not price, 5 of 14 chart checks firingWhat the Quality Score means

+5Chart checks 5 of 14 firing right now, one point each
+2Profit A profit of $2.6B over the last four quarters, up 38% from $1.9B the four before, from the SEC filingsRead on the last four quarters against the four before, or the last full year where no quarters are filed.

Long-term trend adds
Size adds
Persistence adds

No effect today: Run-up, Growth, Dilution, Volatility, Cash flow, News, and Insider trades.

What every line is worth, and the reason behind it, on COR and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 6:23 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Alert me when COR's Quality Score turns up

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Here is what Pro members see.

The same page for Pro members, on AMD
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on COR and every other stock.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

COR has 5 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on COR, and all 14 on every stock.Get in free →

COR RSI today: 60.5, above its 50-day and 200-day averages

Not scored

Not in the Quality Score: over 20 years of tests, 2006 to 2026, they added no edge.

RSI 1460.5
Above 50, below 70.
MACD (12, 26, 9)Below signal
Crossed below its signal line 4 sessions ago.
50-day average$323.77
The price is 4.3% above it.
200-day average$317.00
The price is 6.6% above it.
50/200 crossGolden cross
The 50-day crossed above the 200-day on Oct 7.
ADX 1418.4
Under 25, with +DI above -DI.
Support$336.41
Swing low from Dec 23, 2025, 0.4% below the price.
Resistance$338.71
Swing high from Sep 3, 0.3% above the price.
52-week high$377.54
From Nov 25, 2025, 11.8% above the price.
52-week low$244.82
From May 6, 27.5% below the price.
Chart patternNone
No triangle, channel, or wedge in the last year.
Bollinger Bands (20, 2)Inside
The bands run from $315.01 to $347.45.
Volume1.3x
Against its 20-day average, for the time of day.

The deep dive on COR

What it does and how it makes money3 findingsWalgreens and Boots UK Ltd made up 25% of its revenue in 2025, its 10-K says.SEC filing · Nov 25, 2025
Where it stands4 findingsFor Pro members4 findings on where COR stands: its cash, debt, and share count, for Pro members
What changed in its filings4 findings"On December 30, 2021, the Lebanon County Employees’ Retirement Fund and Teamsters Local 443 Health Services & Insurance Plan filed a complaint for a purported derivative action in the Delaware Court of Chancery against the Company and certain of its current officers and directors." (10-Q for the quarter to Jun 30, 2026)SEC filing · Aug 5, 2026A new heading in its "Risk Factors" this year: "We have been and may in the future be adversely impacted by events outside of our control." (10-K for fiscal 2025; not in fiscal 2024's)SEC filing · Nov 25, 2025, against the one of Nov 26, 2024
Who holds and trades it4 findingsFor Pro members4 findings on who holds and trades COR, for Pro members
Against its closest peers2 peersSales over four quarters against a year before: COR +5.1%, CAH +14%, MCK +8.8%.

12 more findings on COR, each with its source, for Pro membersGet in free →

How COR ranks in Drug Wholesale

COR is #3 of 5 by Quality Score among Wholesale-⁠Drugs, Proprietaries & Druggists' Sundries.

How COR ranks in Drug Wholesale
1	MCKMcKesson	6/14	15
2	CAHCardinal Health	6/14	15
3	CORCencora	5/14	10
	HLFHerbalife		Open for its score
	NUSNuSkin Enterprises		Open for its score

Sales over four quarters against a year before: COR +5.1%, CAH +14%, MCK +8.8%.

More in Drug Wholesale, on the Healthcare page

When does COR report earnings, and what happens after?

Reports Wed Nov 4, before the open (in 2 days). Confirmed.

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What COR reported on Oct 21, 2026

The quarter

The figures are not read from the release yet.

The filing on EDGAR

Where the sales came from

COR's results filing gives no sales by line in a table we read.

The outlook

The outlook the company gave, by period
Measure	Figure
Fiscal year 2026
Adjusted diluted earnings per share (EPS)	at least $17.90raised

Figures as filed (SEC filing, Oct 21)

In the company's words

“Cencora expects the acquisition to be accretive to Cencora’s adjusted diluted EPS in the second year post-closing.”

From its results filing (SEC filing · Oct 21)

The numbers

Market value: $63B; today
Sales: $333B; up 5.1% on the year
Free cash flow: $4.1B; last 12 months

Sales grew 11% a year over 5 years, fiscal 2020 to 2025.

Pays $2.40 a share a year.

5 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on COR: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.Get in free →

-17.4%+3.6%-0.8%

May 6Aug 5Oct 21

Reported	When	Gap	Reaction	5 sessions
Oct 21, 2026Before open	Before open	-0.1%	-0.8%	-5.2%
Aug 5, 2026Before open	Before open	+3.2%	+3.6%	+9.0%
May 6, 2026Before open	Before open	-12.4%	-17.4%	-14.7%

COR closed higher after 1 of its last 4 reports.

All 4 reports, and COR's Quality Score going into each

Everyone reporting earnings this week

COR sales and profit by year

Sales and profit by year

Sales grew every year from 2018 to 2025, to $321B. It made a profit in seven of the eight years.

Insiders trading COR

COR insider trades

2 insiders bought $2.3M across 3 filings, and 2 insiders sold $4.1M across 2 filings, in the last 6 months. The newest:

SellLon R. Greenberg$411KDirectorat $321.30 on Sep 16, filed Sep 17

SellLon R. GreenbergDirector$411Kat $321.30 on Sep 16, filed Sep 17

All 5 insider filings on COR from the last six months, for Pro members.Get in free →

All COR insider trades

COR trades by Congress and the executive branch

14 trades disclosed in the last six months. The newest:

BuyRohit Khanna$1K to $15KHousetraded Sep 4, disclosed Oct 7(33 days later)

BuyRohit KhannaHouse$1K to $15Ktraded Sep 4, disclosed Oct 7(33 days later)

All 14 trades on COR disclosed by Congress and the executive branch, for Pro members.Get in free →

See what Congress is buying across the market

COR's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Robert P. MauchPresident & CEO · 5 trades
James F. ClearyChief Financial Officer
Lazarus KrikorianSVP & Chief Accounting Officer · 3 trades
Elizabeth S. CampbellExecutive Vice President · 2 trades
Silvana BattagliaExecutive Vice President · 1 trade
Pawan VermaEVP, Chief Data & Info Officer
Dermot Mark DurcanDirector · 1 trade
Dermot Mark DurcanDirector · 1 trade

10 more officers and directors file at COR. Each page above names the rest.

See insider trades by person

Which ETFs hold COR?

In ETFs: COR is 0.4% of SPMO, 0.3% of VIG, and 0.1% of DGRO, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jul 31 to Aug 31, 2026.

About Cencora

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

51,000 employeesConshohocken, PAcencora.com

What Cencora says it competes with

“We operate in a highly competitive global environment in the distribution of pharmaceuticals and related healthcare services.”

From its annual report, SEC filing · Nov 25, 2025

2 more sentences and what it says it does, for Pro membersGet in free →

COR's score card

Cencora (COR): Quality Score 10, Average, #3 of 5 in Drug Wholesale, with its price, on Breakaway — The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

What would move COR's score: 5 things
3 more filings explained, a plain line each
Real-⁠time prices, no delay

BreakawayOct 7Rohit Khanna bought COR$1K to $15K, disclosed Oct 7

Alerts are optional.

See COR's 14 chart checks

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Straight Answers

As of Nov 2, 2026: COR's Quality Score is 10 (Average), #3 of 5 in Wholesale-Drugs, Proprietaries & Druggists' Sundries. Insiders bought $2.3M and sold $4.1M in the last 6 months (Form 4).

Is COR a good stock to buy? What its Quality Score says

COR scores 10 today, which Breakaway calls Average. It is #3 of 5 in Wholesale-⁠Drugs, Proprietaries & Druggists' Sundries by Quality Score, with 5 of 14 chart checks firing. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is COR's Quality Score?

COR scores 10 today, which Breakaway calls Average (6 to 10). That is #3 of 5 in Wholesale-⁠Drugs, Proprietaries & Druggists' Sundries by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind COR's 10.

Are insiders buying COR?

2 insiders bought $2.3M across 3 filings, and 2 insiders sold $4.1M across 2 filings, in the last 6 months. The newest is Lon R. Greenberg, Director, who sold $411K on Sep 16. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.